Cabrera‐Galeana, P., Muñoz‐Montaño, W., Lara‐Medina, F., Alvarado‐Miranda, A., Pérez‐Sánchez, V., Villarreal‐Garza, C., . . . Arrieta, O. (2018). Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy. Oncologist.
استشهاد بنمط شيكاغوCabrera‐Galeana, Paula, et al. "Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy." Oncologist 2018.
MLA استشهادCabrera‐Galeana, Paula, et al. "Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy." Oncologist 2018.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.